Up-regulation of krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma

Gastroenterology

Volumn 139, Issue 6, 2010, Pages

  Li, Jiachu ^a,b   Yang, Xinrong ^a   Sun, Haixiang ^a   Xu, Yang ^a   Zhou, Jian ^a   Qiu, Shuangjian ^a   Ke, Aiwu ^a   Cui, Yuehong ^a   Wang, Zhijun ^a   Wang, Weimin ^a   Liu, Kangda ^a   Fan, Jia ^a  

^a FUDAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Liver Cancer; Metastatic Liver Cancer; siRNA; Small Interfering RNA; Tumor Microenvironment

Indexed keywords

FIBRONECTIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 8; NERVE CELL ADHESION MOLECULE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; TISSUE MICROARRAY; UPREGULATION; VALIDATION PROCESS;

EID: 78649710234     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.004     Document Type: Article

References (49)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. J.M. Llovet, and M. Beaugrand Hepatocellular carcinoma: present status and future prospects J Hepatol 38 Suppl 2003 136 149
3. Z.Y. Tang, S.L. Ye, and Y.K. Liu A decade's studies on metastasis of hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 187 196
4. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
5. J.E. Darnell Jr Transcription factors as targets for cancer therapy Nat Rev Cancer 2 2002 740 749
6. S. Safe, and K. Kim Nuclear receptor-mediated transactivation through interaction with Sp proteins Prog Nucleic Acid Res Mol Biol 77 2004 1 36
7. S. Safe, and M. Abdelrahim Sp transcription factor family and its role in cancer Eur J Cancer 41 2005 2438 2448
8. Y. Yang, B.G. Goldstein, and H.H. Chao KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells Cancer Biol Ther 4 2005 1216 1221
9. D.A. Slavin, N.P. Koritschoner, and C.C. Prieto A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function Oncogene 23 2004 8196 8205
10. G. Narla, S. Kremer-Tal, and N. Matsumoto In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma Oncogene 26 2007 4428 4434
11. V. Ellenrieder, A. Buck, and A. Harth KLF11 mediates a critical mechanism in TGF-β signaling that is inactivated by ERK-MAPK in pancreatic cancer cells Gastroenterology 127 2004 607 620
12. J. van Vliet, J. Turner, and M. Crossley Human Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBP and represses transcription Nucleic Acids Res 28 2000 1955 1962
13. X. Wang, M. Zheng, and G. Liu Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion Cancer Res 67 2007 7184 7193
14. Y. Li, B. Tian, and J. Yang Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics J Cancer Res Clin Oncol 130 2004 460 468
15. J.F. Cui, Y.K. Liu, and L.J. Zhang Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis Proteomics 6 2006 5953 5961
16. Q.H. Ye, L.X. Qin, and M. Forgues Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423
17. X.R. Yang, Y. Xu, and B. Yu CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clin Cancer Res 15 2009 5518 5527
18. Q. Gao, S.J. Qiu, and J. Fan Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2007 2586 2593
19. H.C. Sun, W. Zhang, and L.X. Qin Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma J Hepatol 47 2007 684 690
20. X.Y. Yang, Y. Xu, and G.M. Shi Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection Clin Cancer Res 14 2008 3850 3859
21. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
22. M.H. Yang, C.L. Chen, and G.Y. Chau Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma Hepatology 50 2009 1464 1474
23. J. Sjolund, M. Johansson, and S. Manna Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo J Clin Invest 118 2008 217 228
24. T.A. Patterson, E.K. Lobenhofer, and S.B. Fulmer-Smentek Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project Nat Biotechnol 24 2006 1140 1150
25. L. Wang, D. Wei, and S. Huang Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer Clin Cancer Res 9 2003 6371 6380
26. B.C. Fuchs, T. Fujii, and J.D. Dorfman Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells Cancer Res 68 2008 2391 2399
27. G. Christofori New signals from the invasive front Nature 441 2006 444 450
28. J.A. Ludwig, and J.N. Weinstein Biomarkers in cancer staging, prognosis and treatment selection Nat Rev Cancer 5 2005 845 856
29. S.Y. Peng, W.J. Chen, and P.L. Lai High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and β-catenin mutations Int J Cancer 112 2004 44 50
30. L.X. Qin, and Z.Y. Tang Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature J Cancer Res Clin Oncol 130 2004 497 513
31. A. Ferrand, C. Bertrand, and G. Portolan Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursors Cancer Res 65 2005 2770 2777
32. T. Takino, H. Saeki, and H. Miyamori Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions Cancer Res 67 2007 11621 11629
33. C.C. Lynch, T. Vargo-Gogola, and M.D. Martin Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor Cancer Res 67 2007 6760 6767
34. G.W. Dougherty, T. Chopp, and S.M. Qi The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions Exp Cell Res 306 2005 168 179
35. R. Romieu-Mourez, M. Solis, and A. Nardin Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages Cancer Res 66 2006 10576 10585
36. Y. Kim, S. Shintani, and Y. Kohno Cyclin G2 dysregulation in human oral cancer Cancer Res 64 2004 8980 8986
37. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
38. X.R. Yang, Y. Xu, and B. Yu CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clin Cancer Res 15 2009 5518 5527
39. Q. Gao, S.J. Qiu, and J. Fan Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2007 2586 2593
40. R.T. Poon, I.O. Ng, and C. Lau Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study J Clin Oncol 20 2002 1775 1785
41. K.G. Ishak, P.P. Anthony, and Sobin LH Nonepithelial tumors K.G. Ishak, Histological typing of tumors of the liver World Health Organization International Classification of tumors 2nd ed. 1994 Springer Berlin 22 27
42. C. Wittekind Pitfalls in the classification of liver tumors Pathologe 27 2006 289 293
43. F.L. Greene, D.L. Page, and I.D. Fleming AJCC cancer staging manual 6th ed. 2002 Springer New York
44. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
45. X.R. Yang, Y. Xu, and G.M. Shi Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection Clin Cancer Res 14 2008 3850 3859
46. H.C. Sun, W. Zhang, and L.X. Qin Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma J Hepatol 47 2007 684 690
47. M.H. Yang, C.L. Chen, and G.Y. Chau Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma Hepatology 50 2009 1464 1474
48. J. Sjolund, M. Johansson, and S. Manna Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo J Clin Invest 118 2008 217 228
49. X. Wang, M. Zheng, and G. Liu Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion Cancer Res 67 2007 7184 7193